A furious row has broken out between a drugs company and the NHS regulator in England over the price of a new breast cancer treatment.
Kadcyal which is manufactured by Roche Products Limited can give patients with HER2-positive breast cancer an additional six months of life, but the regulator deemed it too expensive.
ITV News correspondent Nina Nannar reports.
More top news
The First Lady gave an enthusiastic backing for the Democratic presidential frontrunner in a speech at the Democratic National Convention.
Vitaly Stepanov, who helped uncover the Russian doping scandal, says the IOC is less concerned about ridding world sport of drug cheats.
Colombian drug lord Daniel Barrera Barrera was fined $10m for manufacturing hundreds of tonnes of cocaine that he trafficked globally.